Visit COVID-19 resources

[Skip to Content]

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study – (Eye 31, 166 (January 2017))

12 January 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login